Observers puzzled by delays in China's approval of BioNTech-Pfizer vaccine

Puzzling?

The potent COVID-19 vaccine developed by Pfizer Inc. and BioNTech SE is widely used in the U.S. and Europe, but China has yet to approve the shot, leaving questions about Beijing’s plans for an inoculation that’s heavily coveted in the rest of the world.

[link to www.japantimes.co.jp (secure)]